Aims, Design and Methods of the "Smoking and Nicotine Dependence Awareness and Screening" (SNICAS) Study;Raucherentwöhnung in der Primärärztlichen Versorgung: Ziele, Design und Methoden der "Smoking and Nicotine Dependence Awareness and Screening (SNICAS)"-Studie

Suchtmedizin in Forschung und Praxis

Volumn 6, Issue 1, 2004, Pages 32-46

  Hoch, Eva ^a,b   Mühlig, Stephan ^a   Höfler, Michael ^b   Sonntag, Holger ^b   Pittrow, David ^a   Wittchen, Hans Ulrich ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Epidemiology; Nicotine dependence; Primary care; Smoking; Smoking cessation

Indexed keywords

NICOTINE;

ADDICTION; ARTICLE; GENERAL PRACTITIONER; GERMANY; MEDICAL SPECIALIST; MENTAL HEALTH; MOTIVATION; PREVALENCE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SCREENING; SMOKING CESSATION; SMOKING HABIT; WORLD HEALTH ORGANIZATION;

EID: 1542314736     PISSN: 14375567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL (1990): Depression and the dynamics of smoking: a national perspective. JAMA 264, 1541-1545
2. th ed). Am Psychiatr Association, Washington
3. APA, American Psychiatric Association (1996): Practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry 153 (suppl. 10), S1-S31
4. Batra A, Buchkremer G (1995): Raucherentwöhnung mit dem Nikotinoflaster. Z Ärztl Fortbild 89, 505-509
5. Beilach BM, Knopf H, Thefeld W (1998): Der Bundesgesundheitssurvey 1997/1998. Das Gesundheitswesen 60 (suppl. 2), 59-68
6. Brandon TH (1994): Negative affect as motivation to smoke. Curr Dir Psychol Sci 3, 33-37
7. Breslau N, Johnson EO (2000): Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 90 (7), 1122-1127
8. Breslau N, Johnson EO, Hiripi E, Kessler R (2001): Nicotine dependence in the United States - prevalence, trends, and smoking persistence. Arch Gen Psychiatry 58, 810-816
9. Buchkremer G, Bents H, Horstmann M, Opitz K, Tölle R (1989): Combination of behavioral smoking cessation with transdermal nicotine substitutution. Addict Behav 14, 229-238
10. Buchkremer G, Minneker E, Block M (1991): Smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy. Pharmacopsychiatry 24, 96-102
11. Bühringer G, Körger C, Küfner H, Lieb R, Schütz C, Soyka M, Wittchen HU (2002): Suchtforschungsverbund ASAT: Entwicklung von Zuordnungsmodellen für Interventionen bei Substanzstörungen. Sucht 48(3), 200-208
12. Colby SM, Tiffany ST, Shiffman S, Niaura R (2000): Review: Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend 59 (suppl. 1), 83-95
13. Cohen D, Barton G (1998): The cost of society of smoking cessation. Thorax 53 (suppl. 2), 38-42
14. Cottler L, Robins LN, Grant B, Blaine J, Towle L, Wittchen HU, et al. (1991): The CIDI-core substance abuse and dependence questions: Cross cultural and nosological issues. Brit J Psychiatr 159, 653-658
15. Cottler LB, Robins LN, Babor T, Helzer J, Towle L, Grant B, et al. (1990): Cross-cultural reliability and acceptability of the CID CIDI-core substance abuse and dependence questions. In: Stefanis CN, Rabavilas AD, Soldatos CR, Hrsg.: Psychiatry: A World Perspective. Proceedings of the VIII World Congress of Psychiatry, Athens, 12-19 October 1989. Excerta Medica, Amsterdam, New York, Oxford, S. 144-152
16. De Wit DJ, Aguilar-Gaziola S, Bijlm R, Borges G, Caraveo-Anduagam JJ, Kessler RC, et al. (im Druck): Cross-national comparisons of drug use and drug-related problems. Addiction
17. Dennis, ML (1998) Integration research and clinical assessment. Measuring client and program needs and outcomes in a changing service environment. National Institute on Drug Abuse's Resource Center for Health Services Research.
18. Etter JF, Perneger TV (1999): A comparison of two measures of stage of change for smoking cessation. Addiction 94(12), 1881-1889
19. Fagerström KO, Schneider NG, Lunell E (1993): Effectiveness of nicotine patch and nicotine gum as individual versus combined treatment for tobacco withdrawal symptoms. Psychopharmacology 111, 271-277
20. Fagerström KO (1994): Combined use of nicotine replacement products. Health Val 18, 15-20
21. Fiore MC, Bailey WC, Cohen SJ et al. (2000): Treating tobacco use and dependence. Clinical practice guideline. U.S. Department of Health and Human Services. Public Health Services, Rockville, MD
22. Fowler G (1997): Smoking cessation: the role of general practitioners, nurses and pharmacists. In: Bolliger CT, Fagerström KO, Hrsg.: The tobacco epidemic. Progress in respiratory research. Karger, Basel, S. 165-177
23. Haustein KO (2000): Pharmacotherapy of nicotine dependence. Int J Clin Pharm Th 38, 273-290
24. Haustein KO (2001): Tabakabhängigkeit - Gesundheitliche Schäden durch das Rauchen. Deutscher Ärzte-Verlag, Köln
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991): The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Brit J Addict 86(9), 1119-1127
26. Hurt RD, Sachs DPL, Glower ED, Offord KP, Johnston JA, Dale LC, et al. (1997): A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337, 1195-1202
27. Jäkle C, Keller S, Baum E, Basler HD (1999): Skalen zur Selbstwirksamkeit und Entscheidungsbalance im Prozess der Verhaltensä nderung von Rauchern. Diagnostica 45(3), 138-146
28. Jarvis MJ (1997): Patterns and predictors of smoking cessation in the general population. In: Bolliger CT, Fagerström KO, Hrsg.: The tobacco epidemic. Progress in respiratory research. Karger, Basel, S. 115-164
29. John U, Hanke M (2001): Tabakrauch-attributable Mortalität in deutschen Bundesländern. Gesundheitswesen 63, 363-369
30. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. (1999): A controlled trial of sustained-release Bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340, 685-691
31. Junge B, Nagel M (1999): Das Rauchverhalten in Deutschland. Gesundheitswesen 61 (suppl. 2), 121-125
32. Junge B, Thamm M (2003): Jahrbuch Sucht 2003, Tabak - Zahlen und Fakten zum Konsum. Neuland-Verlag, Geesthacht, S. 34-61
33. Krause P, Wittchen HU, Höfler M, Winter S, Spiegel B, Pfister H (2001): Generalisierte Angst und Depression in der Allgemeinarztpraxis (GAD-P). Studiendesign und Methodik. MMW-Fortsch Medizin 119 (suppl. 1), 5-12
34. Krause P, Wittchen HU, Küpper B, Sharma AM, Ritz E, Göke B, et al. (2002): The Hypertension and Diabetes Screening and Awareness Study (HYDRA): Aims, design and methods of an innovative epidemiological approach. Eur J Public Health 12 (suppl.), 70
35. Lachner G, Wittchen HU, Perkonigg A, Holly A, Schuster P, Wunderlich U, et al. (1998): Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI). Substance use sections. Eur Addict Res 4(1-2), 28-41
36. Lachner G, Wittchen HU (1996): Das Composite International Diagnostic Interview Substance Abuse Module (CIDI-SAM). In: Mann K, Buchkremer G, Hrsg.: Sucht. Grundlagen, Diagnostik, Therapie. Gustav Fischer, Stuttgart, S. 147-156
37. Lieb R, Schuster P, Pfister H, Fuetsch M, Höfler M, Isensee B, Müller N, Sonntag H, Wittchen HU (2000): Epidemiologie des Konsums, Missbrauchs und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: Die prospektiv-longitudinale Verlaufsstudie EDSP. Sucht 46(1), 18-31
38. Lieb R, Isensee B, von Sydow K, Wittchen H-U (2000): The Early Developmental Stages of Psychopathology Study (EDSP): A methodological update. Eur Addict Res 6(4), 170-182
39. Loddenkemper R, Sybrecht GW (2000): Health care costs of smoking. Eur Respir J 16, 377-378
40. Murray CJL, Lopez AD (1997): Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349, 1269
41. Nelson CB, Wittchen HU (1998b): Editorial: The EDSP: Setting the Stage! Eur Addict Res 4(1-2), 5-7
42. Nelson CB, Wittchen HU (1998a): Smoking and nicotine dependence: Results from a sample of 14 to 24 year olds in Germany. Eur Addict Res 4(1-2), 42-49
43. Perkonigg A, Lieb R, Wittchen HU (1998): Substance use, abuse and dependence in Germany: A review of selected epidemiological data. Eur Addict Res 4(1-2), 8-17
44. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM (1998): Trends in cigarette smoking in the US: Projections to the year 2000. JAMA 261, 61-65
45. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS (1003): Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 12, 399-405
46. Prochaska JO, DiClemente CC (1992): The transtheoretical approach. In: Norcross JC, Goldfried MR, Hrsg.: Handbook of psychotherapy integration, BasicBooks, Inc., New York
47. Ruff LK, Volmer T, Nowak D, Meyer A (2000): The economic impact of smoking in Germany. Eur Respir J 16, 385-390
48. Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R (2003): Linking alcohol- and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit. Addiction 98(4), 509-516
49. Schön S, Nowak D: Medikamentöse Verfahren zur Raucherentwöhnung. Suchtmed 4(3), 189-199
50. Silagy C, Mant D, Fowler G, Lodge M (1994): Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343, 139-142
51. Sonntag H, Hoch E, Jahn B, Spiegel B, Pfister H, Wittchen HU (2003): Tabakentwöhnungsmaßnahmen in der allgemeinärztlichen Versorgung: Implementierung, Effektivität und Wege einer optimierten Alliokation. Suchtmed 5(2), 137-141
52. Sonntag H, Kröger C, Shaw R (1998): Setting up an information system on smoking cessation programmes. IFT Berichte. Band Nr. 96. IFT Institut für Therapieforschung, München
53. Sonntag H, Pfister H, Wittchen HU (1998): Rauchen und Nikotinabhängigkeit in Deutschland. Ergebnisse des bundesweiten Zusatz-Surveys "Psychische Störungen" im Rahmen des Bundes-Gesundheitssurveys
54. Sonntag H, Wittchen HU, Höfler M, Kessler RC, Stein MB (2000): Are social fears and DSM-IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? Eur Psychiat 15(1), 67-74
55. Üstün TB, Wittchen HU (1992): Instruments for the assessment of substance use disorders. Curr Opin Psychiatr 5, 412-419
56. US Department of Health and Human Services (1990). People Health: National Health Promotion and Disease Prevention Objectives. Full Report, Washington.
57. Welte R, König HH, Leidl R (2000): The costs of health damage and productivity losses attributable to cigarette smoking in Germany. Eur J Public Health 10, 31-38
58. WHO, World Health Organization (1990): The Composite International Diagnostic Interview (CDI). World Health Organization, Division of Mental Health, Geneva
59. WHO, World Health Organization (1997): Tobacco or health: a global status report. World Health Organization, Geneva
60. WHO, World Health Organization (2002): Gemeinsam handeln - Tabakkonsum reduzieren: Dokumentation der Abschlusskonferenz des WHO-Partnerschaftsprojektes Tabakabhängigkeit (1999-2002). WHO-Konferenzband.pdf In: www.who-nichtrauchertag.de
61. Winter S, Wittchen HU, Höfler M, Spiegel B, Ormel H, Müller N, Pfister H (2000): Design und Methoden der Studie "Depression 2000". MMW-Fortsch Medizin 118 (suppl. 1), 11-21
62. Wittchen HU, Hrsg. (2000): Depression 2000. Eine bundesweite Depressions-Screening-Studie in Allgemeinarztpraxen. MMW-Fortsch Medizin 118 (suppl. 1/2000), 1-4
63. Wittchen HU, Hrsg. (2003): Die "Hypertension and Diabethes Awareness and Screening"-(HYDRA). MMW-Fortsch Medizin 121, (suppl. 1/2003), 1
64. Wittchen HU, Hrsg. (2001 a): GAD-P-Studie. Bundesweite Studie "Generalisierte Angst und Depression im primärärztlichen Bereich". MMW-Fortsch Medizin 119 (suppl. 1/2001), 1-49
65. Wittchen HU, Hrsg. (2001b): NISAS 2000: Die "Nationwide Insomnia. Screening and Awareness Study (NISAS)". Prävaler, und Verschreibungsverhalten in der allgemeinärztlichen Versorgung. MMW-Fortsch Medizin 119 (suppl. 1/2001), 1-11
66. Wittchen HU, Höfler M, Krause P, Riemann D (2000): The Nationwide Insomnia Screening and Awareness Study (NISAS): Aims, methods and first findings. Abstract P.21.24. The International Journal of Neuropsychopharmacology 3 (suppl. 1), 392
67. Wittchen HU, Höfler M, Meister W (2001a): Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? International Clinical Psychopharmacology 16 (3), 121-135
68. Wittchen HU, Krause P, Höfler M, Winter S, Spiegel B, Hajak G, et al. (2001b): NISAS-2000 - die "Nationale Insomnie Awareness und Screening Studie". Insomnien und Schlafstörungen in der allgemeinä rztlichen Versorgung. Nervenheilkunde 20(1), 4-16
69. Wittchen HU, Nelson CB (1998): Early developmental stages of substance abuse. Eur Addict Res 4, 1-84
70. Wittchen HU, Perkonigg A, Lachner G, Nelson CB (1998): "Early developmental stages of psychopathology study (EDSP)"-Objectives and design. Eur Addict Res 4(1-2), 18-27
71. Wittchen HU, Pfister H, Hrsg. (1997): DIA-X-Interviews: Manual für Screening-Verfahren und Interview. Swets & Zeitlinger, Frankfurt
72. Wittchen HU, Schuster P, Pfister H, Müller N, Storz S, Isensee B (1999): Depressionen in der Allgemeinbevölkerung - schlecht erkannt und selten behandelt. Nervenheilkunde 18, 202-209
73. Wittchen HU, Sonntag H, Nowak D, Kröger C, Schmidt LG (2002): Raucherentwöhnung beim Hausarzt - Illusion oder Perspektive? Der Hausarzt 6, 49-53
74. Zimmer D, Lindinger P, Mitschele U (1993): Neue Wege in der verhaltenstherapeutischen Behandlung des Rauchens. Verhaltenstherapie 3, 304-311